Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS

Glutaredoxin 3 (GLRX3) is antioxidant enzyme, maintaining a low level of ROS, thus contributing to the survival and metastasis of several types of cancer. However, the expression and functions of GLRX3 have not been addressed in nasopharyngeal carcinoma (NPC). In this study, we found that GLRX3 was...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Feng, Wei, Lili, Luo, Wenqi, Liao, Zhipeng, Li, Bo, Zhou, Xiaoying, Xiao, Xue, You, Jingping, Chen, Yufeng, Zheng, Shixing, Li, Ping, Murata, Mariko, Huang, Guangwu, Zhang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095054/
https://www.ncbi.nlm.nih.gov/pubmed/27203742
http://dx.doi.org/10.18632/oncotarget.9454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095054/
https://www.ncbi.nlm.nih.gov/pubmed/27203742
http://dx.doi.org/10.18632/oncotarget.9454

Ejemplares similares